A new trading day began on Tuesday, with Biohaven Ltd (NYSE: BHVN) stock price up 3.25% from the previous day of trading, before settling in for the closing price of $15.39. BHVN’s price has ranged from $12.79 to $55.70 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -49.78% over the last five years. Meanwhile, its annual earnings per share averaged 17.68%. With a float of $92.38 million, this company’s outstanding shares have now reached $105.78 million.
Biohaven Ltd (BHVN) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Biohaven Ltd is 12.68%, while institutional ownership is 82.84%. The most recent insider transaction that took place on Mar 04 ’25, was worth 996,238. In this transaction Director of this company bought 32,700 shares at a rate of $30.47, taking the stock ownership to the 2,320,571 shares. Before that another transaction happened on Dec 30 ’24, when Company’s Director bought 29,000 for $35.94, making the entire transaction worth $1,042,393. This insider now owns 2,368,741 shares in total.
Biohaven Ltd (BHVN) Earnings and Forecasts
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -1.74 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.41 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 17.68% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 22.03% during the next five years compared to -49.78% drop over the previous five years of trading.
Biohaven Ltd (NYSE: BHVN) Trading Performance Indicators
Here are Biohaven Ltd’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.82.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -7.66, a number that is poised to hit -1.88 in the next quarter and is forecasted to reach -5.96 in one year’s time.
Technical Analysis of Biohaven Ltd (BHVN)
Analysing the last 5-days average volume posted by the [Biohaven Ltd, BHVN], we can find that recorded value of 1.35 million was lower than the volume posted last year of 1.71 million. As of the previous 9 days, the stock’s Stochastic %D was 67.34%.
During the past 100 days, Biohaven Ltd’s (BHVN) raw stochastic average was set at 27.51%, which indicates a significant decrease from 88.77% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.83 in the past 14 days, which was lower than the 1.13 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $14.52, while its 200-day Moving Average is $26.52. Now, the first resistance to watch is $16.19. This is followed by the second major resistance level at $16.49. The third major resistance level sits at $16.93. If the price goes on to break the first support level at $15.45, it is likely to go to the next support level at $15.01. Should the price break the second support level, the third support level stands at $14.71.
Biohaven Ltd (NYSE: BHVN) Key Stats
With a market capitalization of 1.68 billion, the company has a total of 105,791K Shares Outstanding. Currently, annual sales are 0 K while annual income is -846,420 K. The company’s previous quarter sales were 0 K while its latest quarter income was -198,150 K.
